​

Orchestra BioMed (OBIO) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Orchestra BioMed Revenue Highlights

Latest Revenue (Y)

$2.64M

Latest Revenue (Q)

$836.00K

Main Segment (Y)

Product

Orchestra BioMed Revenue by Period

Orchestra BioMed Revenue by Year

DateRevenueChange
2024-12-31$2.64M-4.42%
2023-12-31$2.76M-21.88%
2022-12-31$3.53M-551.79%
2021-12-31$-782.00K-113.71%
2020-12-31$5.70M-

Orchestra BioMed generated $2.64M in revenue during NA 2024, up -4.42% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Orchestra BioMed Revenue by Quarter

DateRevenueChange
2025-06-30$836.00K-3.69%
2025-03-31$868.00K243.08%
2024-12-31$253.00K-74.37%
2024-09-30$987.00K26.86%
2024-06-30$778.00K25.48%
2024-03-31$620.00K136.64%
2023-12-31$262.00K-37.47%
2023-09-30$419.00K-54.21%
2023-06-30$915.00K-21.39%
2023-03-31$1.16M5.53%
2022-12-31$1.10M-5.16%
2022-09-30$1.16M190.02%
2022-06-30$401.00K-53.70%
2022-03-31$866.00K-135.30%
2021-12-31$-2.45M-284.02%
2021-09-30$1.33M-236.30%
2021-06-30$-978.00K-174.32%
2021-03-31$1.32M-

Orchestra BioMed generated $836.00K in revenue during Q2 2025, up -3.69% compared to the previous quarter, and up 134.84% compared to the same period a year ago.

Orchestra BioMed Revenue Breakdown

Orchestra BioMed Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23
Product$633.00K$654.00K

Orchestra BioMed's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25Dec 24Sep 24Mar 24
Product$169.00K$136.00K$326.00K$184.00K$123.00K

Orchestra BioMed's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Product (100.00%).

OBIO Revenue FAQ

What is Orchestra BioMed’s yearly revenue?

Orchestra BioMed's yearly revenue for 2024 was $2.64M, representing a decrease of -4.42% compared to 2023. The company's yearly revenue for 2023 was $2.76M, representing a decrease of -21.88% compared to 2022. OBIO's yearly revenue for 2022 was $3.53M, representing a decrease of -551.79% compared to 2021.

What is Orchestra BioMed’s quarterly revenue?

Orchestra BioMed's quarterly revenue for Q2 2025 was $836K, a -3.69% decrease from the previous quarter (Q1 2025), and a 7.46% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $868K, a 243.08% increase from the previous quarter (Q4 2024), and a 40.00% increase year-over-year (Q1 2024). OBIO's quarterly revenue for Q4 2024 was $253K, a -74.37% decrease from the previous quarter (Q3 2024), and a -3.44% decrease year-over-year (Q4 2023).

What is Orchestra BioMed’s revenue growth rate?

Orchestra BioMed's revenue growth rate for the last 3 years (2022-2024) was -25.33%, and for the last 5 years (2020-2024) was -53.74%.

What are Orchestra BioMed’s revenue streams?

Orchestra BioMed's revenue streams in c 24 are Product

What is Orchestra BioMed’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Orchestra BioMed was Product. This segment made a revenue of $633K, representing 100.00% of the company's total revenue.